University of Chicago Medicine is redefining the adoption of digital health solutions with a structured approach that ...

Q4 2024 Earnings Call Transcript March 20, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.05, ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

By incorporating healthspan science into clinical practice, some doctors are navigating a gray area between mainstream ...

At the foundation of healthspan medicine are the pillars of health. These are easily understood through four simple verbs: ...

Medical technology company Sibel Health has secured $30m in an equity financing round to expedite the commercial deployment ...

Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...

Minnesota Head & Neck Pain Clinic orofacial pain specialists explain how to overcome challenges in distinguishing between ...

Sibel Health's journey from Northwestern spinout to FDA-cleared medtech innovator showcases Chicago's rising potential in ...